Purchases and Sales Made in Q3 2022 in Coherus Bio Sciences, Inc. (CHRS)
This table provides information about the institutional ownership of Coherus Bio Sciences, Inc. (CHRS) during Q3 2022. The information is specifically focused on institutions that hold shares of Coherus BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Aristotle Capital Boston, LLC
Boston, MA |
SELL
|
- |
-181K- 7.79% |
$1.3M - $2.51M
|
2.14M
$3.36M
|
|
|
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-278K- 25.8% |
$1.99M - $3.86M
|
800K
$1.26M
|
|
|
Nov 15, 2022
Q3 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-317K- 35.65% |
$2.27M - $4.39M
|
572K
$898K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-361K- 5.57% |
$2.59M - $5.01M
|
6.13M
$9.62M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.28M- 20.01% |
$9.16M - $17.7M
|
5.11M
$8.02M
|
|
|
Nov 14, 2022
Q3 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.98M- 54.27% |
$14.2M - $27.4M
|
1.67M
$2.62M
|